Medtronic Revenue 2006-2018 | MDT

Current and historical revenue for Medtronic (MDT) from 2006 to 2018. Revenue can be defined as the sum of all revenue fields included for a company's operating activities. Medtronic revenue for the twelve months ending April 30, 2018 was $29.953B. Medtronic revenue for the three months ending April 30, 2018 was $8.144B, representing a 2.88% increase from the same quarter last year.
Medtronic Annual Revenue
(Millions of US $)
2018 $29,953
2017 $29,710
2016 $28,833
2015 $20,261
2014 $17,005
2013 $16,590
2012 $16,184
2011 $15,508
2010 $15,392
2009 $14,599
2008 $13,515
2007 $12,299
2006 $11,292
2005 $10,055
Medtronic Quarterly Revenue
(Millions of US $)
Q4 2018 $8,144
Q3 2018 $7,369
Q2 2017 $7,050
Q1 2017 $7,390
Q4 2017 $7,916
Q3 2017 $7,283
Q2 2016 $7,345
Q1 2016 $7,166
Q4 2016 $7,567
Q3 2016 $6,934
Q2 2015 $7,058
Q1 2015 $7,274
Q4 2015 $7,304
Q3 2015 $4,318
Q2 2014 $4,366
Q1 2014 $4,273
Q4 2014 $4,565
Q3 2014 $4,163
Q2 2013 $4,194
Q1 2013 $4,083
Q4 2013 $4,460
Q3 2013 $4,027
Q2 2012 $4,095
Q1 2012 $4,008
Q4 2012 $4,297
Q3 2012 $3,918
Q2 2011 $4,023
Q1 2011 $3,946
Q4 2011 $3,975
Q3 2011 $3,857
Q2 2010 $3,903
Q1 2010 $3,773
Q4 2010 $3,770
Q3 2010 $3,851
Q2 2009 $3,838
Q1 2009 $3,933
Q4 2009 $3,829
Q3 2009 $3,494
Q2 2008 $3,570
Q1 2008 $3,706
Q4 2008 $3,859
Q3 2008 $3,405
Q2 2007 $3,124
Q1 2007 $3,127
Q4 2007 $3,279
Q3 2007 $3,048
Q2 2006 $3,075
Q1 2006 $2,897
Q4 2006 $3,067
Q3 2006 $2,770
Q2 2005 $2,765
Q1 2005 $2,690
Q4 2005 $2,778
Q3 2005 $2,531
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $122.465B $29.953B
Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $112.329B 23.54
Stryker (SYK) United States $62.038B 23.97
Boston Scientific (BSX) United States $46.397B 24.14
Baxter (BAX) United States $38.200B 26.00
Zimmer Biomet Holdings (ZBH) United States $24.941B 16.02
Smith & Nephew SNATS (SNN) United Kingdom $15.395B 0.00
ResMed (RMD) United States $15.384B 30.53
Perrigo (PRGO) Ireland $9.565B 13.57
Bio-Rad Laboratories (BIO) United States $9.531B 61.26
Hill-Rom Holdings (HRC) United States $6.308B 21.40
Canopy Growth (CGC) Canada $6.230B 0.00
ICU Medical (ICUI) United States $5.941B 40.56
Haemonetics (HAE) United States $5.156B 47.05
Insulet (PODD) United States $5.134B 0.00
Agios Pharmaceuticals (AGIO) United States $4.432B 0.00
Hutchison China MediTech (HCM) China $4.374B 0.00
Neogen (NEOG) United States $4.327B 68.95
GW Pharmaceuticals (GWPH) United Kingdom $3.748B 0.00
National Vision Holdings (EYE) United States $3.382B 0.00
NuVasive (NUVA) United States $3.320B 31.49
Quidel (QDEL) United States $2.722B 55.76
Phibro Animal Health (PAHC) United States $1.978B 29.37
NxStage Medical (NXTM) United States $1.856B 0.00
Cardiovascular Systems (CSII) United States $1.252B 752.80
Eagle Pharmaceuticals (EGRX) United States $1.195B 35.26
AtriCure (ATRC) United States $1.103B 0.00
VAREX IMAGING (VREX) United States $1.075B 17.57
OraSure Technologies (OSUR) United States $1.025B 67.04
Orthofix (OFIX) United States $1.012B 30.83
TG Therapeutics (TGTX) United States $0.981B 0.00
Cerus (CERS) United States $0.958B 0.00
Surmodics (SRDX) United States $0.941B 113.63
MacroGenics (MGNX) United States $0.901B 0.00
Owens & Minor (OMI) United States $0.879B 9.41
Omeros (OMER) United States $0.861B 0.00
LeMaitre Vascular (LMAT) United States $0.706B 33.87
PetIQ (PETQ) United States $0.665B 0.00
Meridian Bioscience (VIVO) United States $0.636B 21.74
Insys Therapeutics (INSY) United States $0.554B 0.00
Evolus (EOLS) United States $0.554B 0.00
Lantheus Holdings (LNTH) United States $0.502B 15.60
NanoString Technologies (NSTG) United States $0.417B 0.00
Cytosorbents (CTSO) United States $0.363B 0.00
Utah Medical Products (UTMD) United States $0.340B 21.90
BioLife Solutions (BLFS) United States $0.325B 0.00
Quanterix (QTRX) United States $0.323B 0.00
Surface Oncology (SURF) United States $0.287B 0.00
Rockwell Medical (RMTI) United States $0.244B 0.00
Chimerix (CMRX) United States $0.210B 0.00
Fonar (FONR) United States $0.169B 10.25
Chembio Diagnostics (CEMI) United States $0.162B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.122B 0.00
Female Health (VERU) United States $0.117B 0.00
Trinity Biotech (TRIB) Ireland $0.093B 27.88
United-Guardian (UG) United States $0.086B 18.95
Oramed Pharmaceuticals (ORMP) Israel $0.083B 0.00
CAS Medical Systems (CASM) United States $0.077B 0.00
Neurotrope (NTRP) United States $0.076B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.065B 0.00
Valeritas Holdings (VLRX) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Capricor Therapeutics (CAPR) United States $0.032B 0.00
Akers Biosciences Inc (AKER) United States $0.026B 0.00
Senestech (SNES) United States $0.018B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00